Physician profile
Ashley Utley
NPI 1700442514
$6,744.40
in general payments reported to CMS, 2019-2025
36 companies · $1,982 in 2025
The $1,982 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,010 · 2022: $683 · 2023: $1,547 · 2024: $1,523 · 2025: $1,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,019 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,019.44 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,503.48 | 2021-2025 | |
| Novo Nordisk INC | $697.28 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $696.88 | 2021-2025 | |
| Mannkind Corporation | $579.72 | 2021-2024 | |
| Lilly USA, LLC | $460.87 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $399.56 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Axsome Therapeutics, INC. | $318.13 | 2023-2025 | Symbravo, Auvelity |
| Amgen INC. | $273.40 | 2021-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $227.91 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $209.30 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.28 | 2021-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $163.75 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.73 | 2021-2023 | Xifaxan |
| Glaxosmithkline, LLC. | $115.96 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $113.14 | 2021-2023 | Spravato |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Utley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.